Pentoxifylline is not a promising treatment for multiple sclerosis in progression phase.

Myers, L W

Pentoxifylline is not a promising treatment for multiple sclerosis in progression phase. [electronic resource] - Neurology Nov 1998 - 1483-6 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't

0028-3878

10.1212/wnl.51.5.1483 doi


Adult
Brain--pathology
Disease Progression
Dose-Response Relationship, Drug
Evoked Potentials, Visual--drug effects
Humans
Lymphocytes--immunology
Magnetic Resonance Imaging
Multiple Sclerosis--drug therapy
Pentoxifylline--therapeutic use
Time Factors
Treatment Failure
Tumor Necrosis Factor-alpha--biosynthesis